nocturia nocturia
Conditions
Interventions
crossover design. True food preceding group:Mixture 50mg of nobiletin and tangeretin will be orally administered every day, once after dinner for 6 weeks. After a washout period of 2 weeks, the placeb
Sponsors
Ito Haruki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who has to wake at night more than twice for voiding 2)Patients who has a proper comprehension and compliance 3)50 years old or more patients 4)Patients with ECOG PS 0-2 5)Patients who go to a hospital regularly
Exclusion criteria
Exclusion criteria: 1)Patients with polyuria 2)Residual urine volume is more than 200mL 3)Patients with benign prostatic hyperplasia, over active bladder and neurogenic bladder, who need the treatment other than nocturia 4)Any other patients who are regarded as unsuitable for this study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change of nocturnal functional bladder capacity | — |
Secondary
| Measure | Time frame |
|---|---|
| IPSS/PSQI score, The change on frequency of urination at night, The change of nocturnal urine volume | — |
Contacts
Public ContactHaruki Ito
National Hospital Organization Kyoto Medical Center
Outcome results
None listed